Chair's Address to Shareholders
| Stock | Chrysos Corporation Ltd (C79.ASX) |
|---|---|
| Release Time | 24 Nov 2025, 12:35 p.m. |
| Price Sensitive | Yes |
Chrysos Corporation Chair Addresses Shareholders
- Record FY25 results with 46% revenue growth and 80% EBITDA increase
- Recurring revenue model and accuracy advantage driving strong demand for PhotonAssay™
- Expanded global footprint with new partnerships and deployments
Chrysos Corporation's Chair, Rob Adamson, welcomed shareholders to the 2025 Annual General Meeting, reflecting on another year of solid progress for the company. In FY25, Chrysos achieved record results, with revenue growing 46% to $66.1 million and EBITDA rising 80% to $16.1 million. These outcomes reflect the strength of Chrysos' business model, the growing demand for its PhotonAssay™ technology, and the execution of its strategy. The Chair noted that the company's recurring revenue model, where each PhotonAssay™ unit is deployed under a minimum monthly payment, ensures a stable return, with higher assay volumes translating directly into higher revenue per unit. Chrysos' competitive advantage was also highlighted, as PhotonAssay™ is more accurate than traditional fire assay methods, helping to drive adoption and reinforce the company's position as the industry's preferred solution. Operationally, Chrysos installed 11 new units, bringing the total to 40 deployed globally, and signed nine new leases, ending the financial year with 62 contracted units. The company also completed the build of its next-generation XN unit, which will become the standard for future deployments. Chrysos' global expansion continued with a major milestone, the entry into South America with a deployment in Chile through a partnership with Bureau Veritas. The company now works with 70% of the world's top 20 gold producers, including a new master services agreement with Newmont, the world's largest gold mining company. As Chrysos' installed base grows, the Chair noted the benefits of operational leverage, with improved margins and stronger cash generation across the business. Additionally, the company made meaningful progress in its sustainability agenda, with an independent assessment confirming that PhotonAssay™ delivers substantial environmental and safety advantages over traditional fire assay. Looking ahead, the Chair outlined Chrysos' priorities: accelerating the global roll-out, deepening customer partnerships, and maintaining innovation and operational discipline. With good momentum and a robust financial position, the company is well-placed for another year of growth in FY26 and beyond.
Chrysos Corporation achieved record financial results in FY25, with revenue growing 46% to $66.1 million and EBITDA rising 80% to $16.1 million. The company is well-positioned for continued growth in FY26 and beyond.
Chrysos Corporation's priorities for the year ahead are to accelerate its global roll-out, deepen customer partnerships, and maintain innovation and operational discipline. The company is well-placed for another year of growth in FY26 and beyond.